iXensor, a leading pioneer in the mobile health industry, is proud to announce that our PixoTest® Vision Analysis System (Lipid) has been honored with the 33rd Taiwan Excellence Award, the fourth digital health product of iXensor to receive the Award. As Taiwan’s first portable professional analyzer that delivers results for…
Taipei, Taiwan, June 7th, 2023 – iXensor Co., Ltd. (6734.TWO) iXensor, a leading pioneer in the mobile health industry, will be participating in Medical Taiwan 2023, held in Taipei from June 8th to June 10th (Booth P0312). This year, iXensor’s visionary CEO, Dr. Carson Chen, has been invited to deliver…
Taipei, Taiwan / Düsseldorf, Germany, November 14th, 2022 – iXensor Co., Ltd. (6734. TWO) iXensor, the pioneer of mobile health, today announces that a partnership has been established with Innova Medical Group. Innova Medical Group is a leading global scale-up platform for rapid screening and diagnosis, with notably more than…
iXensor, the pioneer of mobile health, today announced its “PixoTest® COVID -19 Antigen Self-Test Kit” has been granted by Taiwan FDA for EUA, in response to the recent peak of the epidemic and the new quarantine mandate of 0+7 taking effect on Oct 13th, Taiwan will officially enter the era…
From Aug 31st to Sep 2nd, iXensor will present at booth 2P16 of Southeast Asia’s most established trade fair for the medical and healthcare industry – MEDICAL FAIR ASIA 2022. iXensor will exhibit its Taiwan Excellence Gold Award PixoTest® POCT System for infectious and cardiometabolic diseases, and Eveline®, the smartphone-based…
PixoTech® licensing shifted in as iXensor’s new growth engine to meet self-testing strong demand in the post-pandemic era Taipei, Taiwan / Osaka, Japan, April 27th, 2022 – iXensor Co., Ltd. (6734. TWO) iXensor, the pioneer of mobile health, today announced that Rohto Pharmaceutical Co., Ltd, a multinational pharmaceutical corporation headquartered in Japan, has…
iXensor has recently been covered in AFP, Yahoo Finance, and other media about the computer vision-powered PixoTest® COVID-19 Antigen Test can effectively detect Omicron (B.1.1.529) and all major SARS-CoV-2 variants. Read the full news here: https://reurl.cc/Mb1A9m
Taipei, Taiwan – December 22nd, 2021 – iXensor Co., Ltd. (6734.TWO) iXensor, the pioneer of mobile health, declares that its computer vision-powered PixoTest® COVID-19 Antigen Test effectively detects all major SARS-CoV-2 variants including Omicron (B.1.1.529) after completing two validation studies. In response to emerging new waves of the covid-19 pandemic…
Taipei Taiwan – November 24th, 2021 – iXensor Co., Ltd. (6734.TWO) iXensor, the pioneer of mobile health, wins the Taiwan Excellence Gold Award for its computer vision-aided PixoTest® COVID-19 Antigen Test, together with its enterprise PixoHealth Pass Solution. The integrated point-of-care diagnostics and health management SaaS product offers an…
iXensor latest Eveline·Care service enables fertility consultants to access a patient’s fertility data and remotely monitor their conditions in real-time. MobiHealth News and other media have covered this telehealth fertility tool as below: “The Eveline·Care telehealth service enables fertility consultants to access patient’s ovulation test data and recorded symptoms via a…
